Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Truist Securities
- Credit Suisse
- TD Cowen
- Piper Sandler
- B of A Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Hims & Hers Health
What is the target price for Hims & Hers Health (HIMS)?
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hims & Hers Health (HIMS)?
The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.
When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating Hims & Hers Health (HIMS) correct?
While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.